Jacob Brubaker, MD
Glaucoma Specialist · Sacramento, CANPI 1740433945
Payments from drug & device makers
Across 892 payments — averaging $952.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$324K
- Glaukos Corporation$224K
- Alcon Research LLC$102K
- Ivantis, Inc$51K
- Aerie Pharmaceuticals, Inc.$49K
- Alcon$38K
- plus $61K from 20 others
Across 1 payment — averaging $420.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$421
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 308 | $324,169 |
| Glaukos Corporation | 193 | $223,952 |
| Alcon Research LLC | 107 | $102,264 |
| Ivantis, Inc | 17 | $50,743 |
| Aerie Pharmaceuticals, Inc. | 49 | $48,899 |
| Alcon | 94 | $38,145 |
| NEW World Medical,inc. | 43 | $25,846 |
| Rxsight Inc | 16 | $20,354 |
| Iridex Corporation | 7 | $13,667 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $356 |
| Novartis | 6 | $213 |
| Thea Pharma Inc. | 7 | $138 |
| Rayner Intraocular Lenses Limited | 5 | $108 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $59 |
| Nova Eye, Inc. | 1 | $54 |
| Tarsus Pharmaceuticals, Inc. | 3 | $51 |
| Ocular Therapeutix, Inc. | 1 | $50 |
| Sun Pharmaceutical Industries Inc. | 3 | $49 |
| Biotissue Holdings Inc. | 3 | $49 |
| Sight Sciences, Inc. | 2 | $41 |
| Dompe US, Inc. | 1 | $36 |
| Omeros Corporation | 2 | $36 |
| Oyster Point Pharma, Inc. | 2 | $35 |
| Bausch & Lomb Americas Inc. | 2 | $33 |
| Carl Zeiss Meditec USA, Inc. | 1 | $27 |
| Harrow Eye, LLC | 1 | $23 |
How this compares
$849,396 in reported general payments places this provider in the 95th percentile of 64 glaucoma specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other glaucoma specialist in Sacramento
- Sina VahediSacramento$2K
- Tessnim AhmadSacramento$1K
- Jason BacharachPetaluma$2.4M
- Andrew CampSan Diego$511K
- Robert ChangStanford$490K
- Billy PanBeverly Hills$251K
- Daniel KrivoyCulver City$171K
- Felise May BarteSanta Clara$121K
- Houman VosoghiWestlake Village$119K
- Jeffrey GoldbergStanford$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.